This exploratory research suggests that GLP-1 receptor agonists may reduce activation in reward-related brain areas when participants view images of high-calorie foods, potentially contributing to reduced food cravings and hedonic eating behaviours
Use the general adult range as a baseline and adjust up for heat, exercise, or any GI symptoms
You might notice: Loose, watery stools Urgency (the I need to go now feeling) Cramping or a tight, unsettled belly Feeling wiped out, weak, or drained afterward Sometimes diarrhea can show up alongside nausea, or after a dose increase, or on a day when your appetite has been extra low
Compound Library Volume I Phase 3 TRIUMPH Retatrutide Triple-receptor agonist Triple-Receptor Metabolic Peptide Retatrutide is an investigational metabolic peptide being studied for its simultaneous activity at GLP-1, GIP, and glucagon receptors